KD Logo

Emergent Biosolutions Inc (EBS) gets rating Initiated from Rodman & Renshaw

Emergent Biosolutions Inc’s filing revealed that its Director DeGolyer Donald W unloaded Company’s shares for reported $0.27 million on Nov 12 ’24. In the deal valued at $10.91 per share,25,000 shares were sold. As a result of this transaction, DeGolyer Donald W now holds 111,100 shares worth roughly $0.96 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, White Marvin L sold 14,287 shares, generating $171,015 in total proceeds. Upon selling the shares at $11.97, the Director now owns 54,092 shares.

Before that, DeGolyer Donald W bought 25,000 shares. Emergent Biosolutions Inc shares valued at $294,250 were divested by the Director at a price of $11.77 per share.

Rodman & Renshaw initiated its Emergent Biosolutions Inc [EBS] rating to a Buy in a research note published on August 22, 2024; the price target was $16. A number of analysts have revised their coverage, including The Benchmark Company’s analysts, who increased its forecast for the stock in early March from “a Hold” to “a Buy”. The Benchmark Company revised its rating on August 29, 2023. It rated EBS as “a Hold” which previously was an “a Buy”.

Price Performance Review of EBS

On Monday, Emergent Biosolutions Inc [NYSE:EBS] saw its stock jump 11.40% to $8.60. Over the last five days, the stock has lost -28.15%. Emergent Biosolutions Inc shares have risen nearly 258.33% since the year began. Nevertheless, the stocks have risen 305.66% over the past one year. While a 52-week high of $15.10 was reached on 07/30/24, a 52-week low of $1.42 was recorded on 02/06/24. SMA at 50 days reached $8.68, while 200 days put it at $6.36.

Levels Of Support And Resistance For EBS Stock

The 24-hour chart illustrates a support level at 8.03, which if violated will result in even more drops to 7.47. On the upside, there is a resistance level at 8.94. A further resistance level may holdings at 9.29. The Relative Strength Index (RSI) on the 14-day chart is 45.24, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.18, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 82.27%. Stochastics %K at 10.97% indicates the stock is a buying.

How much short interest is there in Emergent Biosolutions Inc?

A steep rise in short interest was recorded in Emergent Biosolutions Inc stocks on 2024-10-31, dropping by -1.28 million shares to a total of 6.95 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-30 was 8.23 million shares. There was a decline of -18.43%, which implies that there is a negative sentiment for the stock.

Most Popular